[HTML][HTML] Utility of Polygenic Risk Scores (PRSs) in Predicting Pancreatic Cancer: A Systematic Review and Meta-Analysis of Common-Variant and Mixed Scores with …
Introduction: Pancreatic cancer remains among the top five causes of cancer-related
mortality. Only 18% to 20% of patients present with early-stage, potentially curable disease …
mortality. Only 18% to 20% of patients present with early-stage, potentially curable disease …
Polygenic risk scores: A conceptual overview to add PRS to your clinical toolbox
E Spaeth - Implementation of Personalized Precision Medicine, 2025 - Elsevier
Polygenic risk scores (PRS) are a newer tool available in the clinical landscape that can
assign a level of risk to your patient in a disease, or phenotype-specific manner. Polygenic …
assign a level of risk to your patient in a disease, or phenotype-specific manner. Polygenic …
3. SMART Medical Review: CA 19-9 and pancreatic ductal adenocarcinoma (PDAC).: CA 19-9 and Pancreatic Cancer
D Whitcomb, TDF Oranburg, R Vallente… - SMART-MD Journal of …, 2024 - smart-md.org
Carbohydrate antigen 19-9 (CA 19-9) is the sole FDA-approved serum biomarker for early
detection, progression, and treatment response of pancreatic ductal adenocarcinoma …
detection, progression, and treatment response of pancreatic ductal adenocarcinoma …
[引用][C] Re: Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model‐based analysis
EB Lockie, J Zalcberg, A Skandarajah… - ANZ Journal of …, 2024 - Wiley Online Library